These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18308730)

  • 1. Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression.
    Ramsay AJ; Dong Y; Hunt ML; Linn M; Samaratunga H; Clements JA; Hooper JD
    J Biol Chem; 2008 May; 283(18):12293-304. PubMed ID: 18308730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.
    Gratio V; Beaufort N; Seiz L; Maier J; Virca GD; Debela M; Grebenchtchikov N; Magdolen V; Darmoul D
    Am J Pathol; 2010 Mar; 176(3):1452-61. PubMed ID: 20056842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1.
    Wang W; Mize GJ; Zhang X; Takayama TK
    Int J Cancer; 2010 Feb; 126(3):599-610. PubMed ID: 19795418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells.
    Kryza T; Silva LM; Bock N; Fuhrman-Luck RA; Stephens CR; Gao J; Samaratunga H; ; Lawrence MG; Hooper JD; Dong Y; Risbridger GP; Clements JA
    Mol Oncol; 2017 Oct; 11(10):1307-1329. PubMed ID: 28510269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells.
    Gratio V; Loriot C; Virca GD; Oikonomopoulou K; Walker F; Diamandis EP; Hollenberg MD; Darmoul D
    Am J Pathol; 2011 Nov; 179(5):2625-36. PubMed ID: 21907696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells.
    Wilson S; Greer B; Hooper J; Zijlstra A; Walker B; Quigley J; Hawthorne S
    Biochem J; 2005 Jun; 388(Pt 3):967-72. PubMed ID: 15537383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intracellular carboxyl tail of the PAR-2 receptor controls intracellular signaling and cell death.
    Zhu Z; Stricker R; Li Ry; Zündorf G; Reiser G
    Cell Tissue Res; 2015 Mar; 359(3):817-27. PubMed ID: 25519044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries.
    Matsumura M; Bhatt AS; Andress D; Clegg N; Takayama TK; Craik CS; Nelson PS
    Prostate; 2005 Jan; 62(1):1-13. PubMed ID: 15389820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors.
    Abdallah RT; Keum JS; El-Shewy HM; Lee MH; Wang B; Gooz M; Luttrell DK; Luttrell LM; Jaffa AA
    J Biol Chem; 2010 Nov; 285(45):35206-15. PubMed ID: 20826789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: implications for xenograft models of human prostate cancer.
    Lisle JE; Mertens-Walker I; Stephens CR; Stansfield SH; Clements JA; Herington AC; Stephenson SA
    Exp Cell Res; 2015 Apr; 333(1):136-46. PubMed ID: 25724897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4.
    Swedberg JE; Nigon LV; Reid JC; de Veer SJ; Walpole CM; Stephens CR; Walsh TP; Takayama TK; Hooper JD; Clements JA; Buckle AM; Harris JM
    Chem Biol; 2009 Jun; 16(6):633-43. PubMed ID: 19549601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Cancer-Associated Kallikrein-Related Peptidase 4 Activates Matrix Metalloproteinase-1 and Thrombospondin-1.
    Fuhrman-Luck RA; Stansfield SH; Stephens CR; Loessner D; Clements JA
    J Proteome Res; 2016 Aug; 15(8):2466-78. PubMed ID: 27378148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer.
    Seiz L; Kotzsch M; Grebenchtchikov NI; Geurts-Moespot AJ; Fuessel S; Goettig P; Gkazepis A; Wirth MP; Schmitt M; Lossnitzer A; Sweep FC; Magdolen V
    Biol Chem; 2010 Apr; 391(4):391-401. PubMed ID: 20180634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.
    Johnson JJ; Miller DL; Jiang R; Liu Y; Shi Z; Tarwater L; Williams R; Balsara R; Sauter ER; Stack MS
    J Biol Chem; 2016 Mar; 291(13):6936-45. PubMed ID: 26839311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer.
    Klokk TI; Kilander A; Xi Z; Waehre H; Risberg B; Danielsen HE; Saatcioglu F
    Cancer Res; 2007 Jun; 67(11):5221-30. PubMed ID: 17545602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin.
    Driesbaugh KH; Buzza MS; Martin EW; Conway GD; Kao JP; Antalis TM
    J Biol Chem; 2015 Feb; 290(6):3529-41. PubMed ID: 25519908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
    Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
    Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypsin stimulates the phosphorylation of p42,44 mitogen-activated protein kinases via the proteinase-activated receptor-2 and protein kinase C epsilon in human cultured prostate stromal cells.
    Myatt A; Hill SJ
    Prostate; 2005 Jul; 64(2):175-85. PubMed ID: 15678497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLK4T2 Is a Hormonally Regulated Transcript from the
    Lundwall Å; Ylitalo EB; Wikström P; Brattsand M
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.